Multiple Manufacturers

FERRLECIT

Manufacturer:

Multiple Manufacturers

Ferrlecit HCPCS:

J2916

HCPCS Code Descriptor:

Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg

Category:

J Code

Ferrlecit NDCs:

00143-9298-10, 00143-9570-10, 00024-2794-10, 00024-2792-10

Primary Type:

Anti-Anemia

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00143-9298-10, 00143-9570-10, 00024-2794-10, 00024-2792-10

About Ferrlecit:

FERRLECIT is a medication manufactured by multiple manufacturers and aligned to the J Code: J2916. FERRLECIT is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J2916 Added Date:

January 1, 2003

J2916 Effective Date:

January 1, 2003

J2916 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Ferrlecit billing and coding information.
Our team did not identify a source for Ferrlecit patient assistance information. Please reach out to our team if you feel that this is a mistake.
FERRLECIT prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for FERRLECIT. Please check back in a few weeks.